octreotide
chemical compound
Facts
18 properties- Instance of
- type of chemical entity
- Has use
- medication
- Active ingredient in
- Sandostatin
- Canonical SMILES
- CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O
- Chemical formula
- C₄₉H₆₆N₁₀O₁₀S₂
- Defined daily dose
- +0.7
- Different from
- 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide, (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
- Isomeric SMILES
- C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@H](N)CC2=CC=CC=C2)C(=O)N[C@@H](CC3=CC=CC=C3)C(=O)N[C@H](CC4=CNC5=C4C=CC=C5)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1
- LiverTox likelihood score
- LiverTox toxicity likelihood category C
- MCN code
- 3004.39.26, 3003.39.25
- Mass
- +1018.44048
- Medical condition treated
- follicular adenoma, acromegaly, pituitary carcinoma, pancreatic cancer, neuroendocrine carcinoma, carcinoid syndrome, carcinoid tumor
- NCI Thesaurus ID
- C711
- Pregnancy category
- Australian pregnancy category C, US pregnancy category B
- Stylized name
- SandoSTATIN
- Subject has role
- gastrointestinal agent, hormonal antineoplastic agent
- World Health Organisation international non-proprietary name
- octreotide
🏷️ Also known as
en octreotide
en SMS995
en octrotide
ar أوكتريوتيد
de Octreotid
el οκτρεοτίδη
es Octreotida
fa اکترئتاید
fa اکترئتید
fr octréotide
he אוקטראוטיד
id Okreotida
ja オクトレオチド
ko 옥트레오티드
pl oktreotyd
ru октреотид
tr Oktreotid
zh 善宁
zh 奥曲肽
zh 奧曲肽
🔖 Identifiers · 32
- GND ID
- 4204319-0
- OpenAlex ID
- C2781025020
- ATC code
- H01CB02
- CAS Registry Number
- 83150-76-9
- ChEBI ID
- 7726
- DSSTOX compound identifier
- DTXCID6028608
- DSSTox substance ID
- DTXSID0048682
- DrugBank ID
- DB00104
- Freebase ID
- /m/04_f23
- Gran Enciclopèdia Catalana ID
- octreotida
- Gran Enciclopèdia Catalana ID (former scheme)
- 0276206
- Human Metabolome Database ID
- HMDB0014262
Show all 32 identifiers +20
- KEGG ID
- D00442
- LiverTox ID
- Octreotide
- MeSH descriptor ID
- D015282
- MeSH tree code
- D04.345.566.650, D12.644.641.650
- Microsoft Academic ID (discontinued)
- 2781025020
- NALT ID
- 148788
- NDF-RT ID
- N0000147950
- NE.se ID
- sandostatin
- PatientsLikeMe treatment ID
- octreotide
- Probes And Drugs ID
- PD014663
- PubChem CID
- 448601
- RxNorm CUI
- 7617
- SureChEMBL ID
- 10044649
- UNII
- RWM8CCW8GP
- UniChem compound ID
- 531330
- WikiProjectMed ID
- Octreotide
- World Health Organisation international non-proprietary name numeric ID
- 5656
🔗 Connections
Medical condition treated 4
← Drug or therapy used for treatment 4
Has use 1
Press Enter · cited answer in seconds
0 sources
Summary
octreotide is a type of chemical entity[1].
Key Facts
- Canonical SMILES: CC(C1C(=O)NC(CSSCC(C(=O)NC(C(=O)NC(C(=O)NC(C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)C(CC5=CC=CC=C5)N)C(=O)NC(CO)C(C)O)O[2]
- Chemical formula: C₄₉H₆₆N₁₀O₁₀S₂[3]
- Subclass of: (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide[4]
- Has use: medication[5]
- NCI Thesaurus ID: C711[6]
- Different from: 10-(4-aminobutyl)-19-[(2-amino-3-phenylpropanoyl)amino]-16-benzyl-N-(1,3-dihydroxybutan-2-yl)-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide[7], (4R,7S,10S,13R,16S,19R)-10-(4-aminobutyl)-16-benzyl-N-[(2R,3R)-1,3-dihydroxy-2-butanyl]-7-(1-hydroxyethyl)-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-19-(D-phenylalanylamino)-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide[8]
- MCN code: 3004.39.26[9], 3003.39.25[10]
- Isomeric SMILES: CC@@HC@@HNC(=O)[C@@H]1CSSCC@HC(=O)NC@@HC(=O)NC@HC(=O)NC@@HC(=O)NC@@HC(=O)N1C@@HC@@HNC(=O)[C@@H]1CSSCC@HC(=O)NC@@HC(=O)NC@HC(=O)NC@@HC(=O)N[C@@H]([C@">[11]
- Mass: 1018.44048 dalton[12]
- Medical condition treated: follicular adenoma[13], acromegaly[14], pituitary carcinoma[15], pancreatic cancer[16], neuroendocrine carcinoma[17], carcinoid syndrome[18], carcinoid tumor[19]
- World Health Organisation international non-proprietary name: octreotide[20]
- Subject has role: gastrointestinal agent[21], hormonal antineoplastic agent[22]
- Pregnancy category: Australian pregnancy category C[23], US pregnancy category B[24]
- Active ingredient in: Sandostatin[25]
- Defined daily dose: 0.7 milligram[26]
- LiverTox likelihood score: LiverTox toxicity likelihood category C[27]
- Stylized name: SandoSTATIN[28]